The application of aptamer 5TR1 in triple negative breast cancer target therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The application of aptamer 5TR1 in triple negative breast cancer target therapy
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 1, Pages 896-908
Publisher
Wiley
Online
2017-07-03
DOI
10.1002/jcb.26254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aptamers: versatile molecular recognition probes for cancer detection
- (2016) Hongguang Sun et al. ANALYST
- Overexpression of the MUC1 Gene in Iranian Women with Breast Cancer Micrometastasis
- (2016) Neda Mansouri et al. Asian Pacific Journal of Cancer Prevention
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Aptamers: A promising chemical antibody for cancer therapy
- (2016) Gang Zhou et al. Oncotarget
- MUC1 as a Potential Target in Anticancer Therapies
- (2015) Krishna Pillai et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Nucleic Acid Aptamer-Mediated Drug Delivery for Targeted Cancer Therapy
- (2014) Huijie Zhu et al. ChemMedChem
- Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery
- (2014) Jie Liao et al. Expert Opinion on Drug Delivery
- MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression
- (2014) Yu Hu et al. PLoS One
- Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells
- (2013) Scott H. Medina et al. BIOMATERIALS
- Reversal of Paclitaxel Resistance in Epithelial Ovarian Carcinoma Cells by a MUC1 Aptamer-let-7i Chimera
- (2012) Nenghui Liu et al. CANCER INVESTIGATION
- Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer
- (2012) Ling Meng et al. PLoS One
- Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance
- (2012) K. Meirelles et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux
- (2011) Xuguang Zhang et al. CANCER LETTERS
- A Novel Aptamer Developed for Breast Cancer Cell Internalization
- (2011) Kejing Zhang et al. ChemMedChem
- Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells
- (2011) Chenghui Huang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Biomarkers of Breast Cancer Apoptosis Induced by Chemotherapy and TRAIL
- (2011) Sharon Leong et al. JOURNAL OF PROTEOME RESEARCH
- Neoadjuvant systemic treatment of breast cancer
- (2011) Issam Makhoul et al. JOURNAL OF SURGICAL ONCOLOGY
- Global Patterns of Cancer Incidence and Mortality Rates and Trends
- (2010) A. Jemal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Aptamer applications for targeted cancer therapy
- (2010) Andrew S Barbas et al. Future Oncology
- MUC1 immunotherapy
- (2010) Richard E Beatson et al. Immunotherapy
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status
- (2008) Yan A. Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Preoperative Therapy in Invasive Breast Cancer: Pathologic Assessment and Systemic Therapy Issues in Operable Disease
- (2008) Julie R. Gralow et al. JOURNAL OF CLINICAL ONCOLOGY
- Phototoxic aptamers selectively enter and kill epithelial cancer cells
- (2008) Cátia S. M. Ferreira et al. NUCLEIC ACIDS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started